Skip to main content
Log in

Using CT to evaluate mediastinal great vein invasion by thymic epithelial tumors: measurement of the interface between the tumor and neighboring structures

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

For thymic epithelial tumors, simple contact with adjacent structures does not necessarily mean invasion. The purpose of our study was to develop a simple noninvasive technique for evaluating organ invasion using routine pretreatment computed tomography (CT).

Methods

This retrospective study analyzed the pathological reports on 95 mediastinal resections performed between January 2003 and June 2020. Using CT images, the length of the interface between the primary tumor and neighboring structures (arch distance; Adist) and maximum tumor diameter (Dmax) was measured, after which Adist/Dmax (A/D) ratios were calculated. Receiver operating characteristic (ROC) curves were used to analyze the Adist and A/D ratios.

Results

An Adist cut-off of 37.5 mm best distinguished between invaded and non-invaded mediastinal great veins based on ROC curves. When Adist > 37.5 mm was used for diagnosis of invasion of the brachiocephalic vein (BCV) or superior vena cava (SVC), the sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and area under the ROC curve for diagnosis of invasion were 61.9%, 92.5%, 81.25%, 82.2%, 81.97%, and 0.76429, respectively. Moreover, there were significant differences between BCV/SVC Adist > 37.5 mm and ≤ 37.5 mm for 10-year relapse-free survival and 10-year overall survival (p < 0.01).

Conclusions

When diagnosing invasion of the mediastinal great veins based on Adist > 37.5 mm, we achieved a higher performance level than the conventional criteria such as irregular interface with an absence of the fat layer. Measurement of Adist is a simple noninvasive technique for evaluating invasion using CT.

Key Points

Simple contact between the primary tumor and adjacent structures on CT does not indicate direct invasion.

Using CT images, the length of the interface between the primary tumor and neighboring structures (arch distance; Adist) is a simple noninvasive technique for evaluating invasion.

Adist > 37.5 mm can be a supportive tool to identify invaded mediastinal great veins and surgical indications for T3 and T4 invasion by thymic epithelial tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

A/D ratio:

The Adist-to-Dmax ratio

Adist:

Length of the interface between the primary tumor and neighboring structures

AUC:

The areas under the ROC curves

BCV:

Brachiocephalic vein

Dmax:

Maximum tumor diameter

ECG:

Electrocardiogram

FDG-PET:

[18F] Fluoro-2-deoxy-D-glucose-positron emission tomography

IASLC:

International Association for the Study of Lung Cancer

ITMIG:

International Thymic Malignancies Interest Group

NCCN:

National Comprehensive Cancer Network

NPV:

Negative predictive value

OS:

Overall survival

PPV:

Positive predictive value

RFS:

Relapse-free survival

ROC curves:

Receiver operating characteristic curves

SUV:

The standardized uptake value

SVC:

Superior vena cava

UICC:

Union for International Cancer Control

VATS:

Video-assisted thoracic surgery

WHO:

World Health Organization

References

  1. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492

    CAS  PubMed  Google Scholar 

  2. Koga K, Matsuno Y, Noguchi M et al (1994) A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44:359–367

    CAS  PubMed  Google Scholar 

  3. Detterbeck FC, Stratton K, Giroux D et al (2014) The IASLC/ ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 9(9 Suppl 2):S65–S72

    PubMed  Google Scholar 

  4. Qu YJ, Liu GB, Shi HS, Liao MY, Yang GF, Tian ZX (2013) Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage. Acad Radiol 20:66–72

    PubMed  Google Scholar 

  5. Marom EM (2013) Advances in thymoma imaging. J Thorac Imaging 28:69–80

    PubMed  Google Scholar 

  6. Ozawa Y, Hara M, Shimohira M, Sakurai K, Nakagawa M, Shibamoto Y (2016) Associations between computed tomography features of thymomas and their pathological classification. Acta Radiol 57:1318–1325

    PubMed  Google Scholar 

  7. Imai K, Minamiya Y, Ishiyama K et al (2013) Use of CT to evaluate pleural invasion in non-small cell lung cancer: measurement of the ratio of the interface between tumor and neighboring structures to maximum tumor diameter. Radiology 267:619–626

    PubMed  Google Scholar 

  8. Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, Chichester

    Google Scholar 

  9. Hayes SA, Huang J, Plodkowski AJ et al (2014) Preoperative computed tomography findings predict surgical resectability of thymoma. J Thorac Oncol 9:1023–1030

    PubMed  Google Scholar 

  10. Hayes SA, Huang J, Golia Pernicka J et al (2018) Radiographic predictors of resectability in thymic carcinoma. Ann Thorac Surg 106:242–248

    PubMed  PubMed Central  Google Scholar 

  11. Hanley JA, McNeil BJ (1983) A method of comparing the area under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843

    CAS  PubMed  Google Scholar 

  12. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    CAS  Google Scholar 

  13. Shen Y, Ye J, Fang W et al (2017) Efficacy of computed tomography features in predicting stage III thymic tumors. Oncol Lett 13:29–36

    PubMed  Google Scholar 

  14. Marom EM, Milito MA, Moran CA et al (2011) Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6:1274–1281

    PubMed  Google Scholar 

  15. Liu GB, Qu YJ, Liao MY, Hu HJ, Yang GF, Zhou SJ (2012) Relationship between computed tomography manifestations of thymic epithelial tumors and the WHO pathological classification. Asian Pac J Cancer Prev 13:5581–5585

    PubMed  Google Scholar 

  16. Lee JH, Park CM, Park SJ, Bae JS, Lee SM, Goo JM (2015) Value of computerized 3D shape analysis in differentiating encapsulated from invasive thymomas. PLoS One 10(5):e0126175

    PubMed  PubMed Central  Google Scholar 

  17. Scagliori E, Evangelista L, Panunzio A et al (2015) Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review. Thoracic Cancer 6:433–442

    PubMed  PubMed Central  Google Scholar 

  18. Ozawa Y, Hara M, Nakagawa M, Shibamoto Y (2016) Utility of electrocardiography (ECG)-gated computed tomography (CT) for preoperative evaluations of thymic epithelial tumors. Pol J Radiol 81:566–571

    PubMed  PubMed Central  Google Scholar 

  19. Chang S, Hur J, Im DJ et al (2017) Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours an initial experience. Eur Radiol 27:1992–2001

    PubMed  Google Scholar 

  20. Choe J, Lee SM, Lim S et al (2017) Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol 27:4030–4036

    PubMed  Google Scholar 

  21. Shen Q, Shan Y, Xu W et al (2020) Risk stratification of thymic epithelial tumors by using a nomogram combined with radiomic features and TNM staging. Eur Radiol 31:423–435

    PubMed  Google Scholar 

  22. Kim ES, Putnam JB, Komaki R et al (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consoli- dation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44:369–379

    PubMed  Google Scholar 

  23. Ströbel P, Marx A, Zettl A, Müller-Hermelink HK (2005) Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 35:805–811

    PubMed  Google Scholar 

  24. Marulli G, Lucchi M, Margaritora S et al (2011) Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers. Eur J Cardiothorac Surg 39:e1-7

    PubMed  Google Scholar 

  25. Higuchi T, Taki J, Kinuya S et al (2001) Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy. Radiology 221:201–206

    CAS  PubMed  Google Scholar 

  26. Sakai S, Murayama S, Soeda H, Matsuo Y, Ono M, Masuda K (2002) Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol 43:262–268

    CAS  PubMed  Google Scholar 

  27. Takahashi K, Inaoka T, Murakami N et al (2003) Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging. AJR Am J Roentgenol 180:1265–1269

    PubMed  Google Scholar 

  28. Ferdinand B, Gupta P, Kramer EL (2004) Spectrum of thymic uptake at 18F-FDG PET. Radiographics 24:1611–1616

    PubMed  Google Scholar 

  29. Seki S, Koyama H, Ohno Y et al (2014) Diffusion-weighted MR imaging vs. multi-detector row CT: direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 83:835–842

    PubMed  Google Scholar 

  30. Yabuuchi H, Matsuo Y, Abe K et al (2015) Anterior mediastinal solid tumours in adults: character- isation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. Clin Radiol 70:1289–1298

    CAS  PubMed  Google Scholar 

  31. Sadohara J, Fujimoto K, Müller NL et al (2006) Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 60:70–79

    PubMed  Google Scholar 

  32. Takahashi K, Al-Janabi NJ (2010) Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 32:1325–1339

    PubMed  Google Scholar 

  33. Li B, Xin YK, Xiao G et al (2019) Predicting pathological subtypes and stages of thymic epithelial tumors using DWI: value of combining ADC and texture parameters. Eur Radiol 29:5330–5340

    PubMed  Google Scholar 

  34. Podoloff DA, Ball DW, Ben-Josef E et al (2009) NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 7(Suppl 2):S1–S26

    PubMed  Google Scholar 

  35. Benveniste MF, Moran CA, Mawlawi O et al (2013) FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol 8:502–510

    PubMed  Google Scholar 

  36. Watanabe T, Shimomura H, Mutoh T et al (2019) Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors. Surg Today 49:143–149

    CAS  PubMed  Google Scholar 

  37. Sharma P, Singhal A, Kumar A, Bal C, Malhotra A, Kumar R (2013) Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review. Acta Radiol 54:14–21

    PubMed  Google Scholar 

  38. Kornstein MJ (1995) Pathology of the thymus and mediastinum. Saunders, Philadelphia, PA

    Google Scholar 

  39. Kumar A, Regmi SK, Dutta R et al (2009) Characterization of thymic masses using 18F-FDG PET-CT. Ann Nucl Med 23:569–577

    PubMed  Google Scholar 

  40. Kim JY, Kim HO, Kim JS et al (2010) (18)F-FDG PET/CT is useful for pretreatment assessment of the histopathologic type of thymic epithelial tumors. Nucl Med Mol Imaging 44:177–184

    PubMed  PubMed Central  Google Scholar 

  41. Inoue A, Tomiyama N, Tatsumi M et al (2009) (18)F-FDG PET for the evaluation of thymic epithelial tumors: correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging 36:1219–1225

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Profs. Hiroshi Nanjo (Department of pathology, Akita University Graduate School of Medicine) and Akiteru Goto (Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine) for suggesting pathological diagnoses.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuhiro Imai.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Yoshihiro Minamiya.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• diagnostic or prognostic study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 171 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuriyama, S., Imai, K., Ishiyama, K. et al. Using CT to evaluate mediastinal great vein invasion by thymic epithelial tumors: measurement of the interface between the tumor and neighboring structures. Eur Radiol 32, 1891–1901 (2022). https://doi.org/10.1007/s00330-021-08276-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-021-08276-z

Keywords

Navigation